Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Pancreatic Neoplasms 16Multiple Myeloma 13Neoplasms 12Colorectal Neoplasms 8Neoplasms, Plasma Cell 7Myelodysplastic Syndromes 7Leukemia, Myeloid, Acute 6Glioblastoma 5Sarcoma 4Prostatic Neoplasms 4Leukemia, Myelomonocytic, Chronic 4Carcinoma, Non-Small-Cell Lung 4Breast Neoplasms 4Skin Neoplasms 3Inflammation 3Colonic Neoplasms 3Stomatitis 2Stomach Neoplasms 2Recurrence 2Primary Myelofibrosis 2Ovarian Neoplasms 2Neoplasms by Site 2Myofibroma 2Myeloproliferative Disorders 2Lymphoma 2Lung Neoplasms 2Liver Neoplasms 2Leukemia 2Glioma 2Frailty 2

Interventions

Temozolomide 131Radiotherapy 87Bevacizumab 43Radiation 31Carmustine 29Magnetic Resonance Spectroscopy 22Irinotecan 22Erlotinib Hydrochloride 22Chemotherapy, Adjuvant 20Surgical Procedures, Operative 15O(6)-benzylguanine 15Carboplatin 14Radiotherapy, Intensity-Modulated 13Radiotherapy, Conformal 13sargramostim 12Sirolimus 9Imatinib Mesylate 9Filgrastim 9Drug Therapy 9temsirolimus 8Thalidomide 8Sorafenib 8Radiosurgery 8pembrolizumab 7motexafin gadolinium 7aldesleukin 7Vorinostat 7Procarbazine 7Gene Expression Profiling 7Gefitinib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gliosarcoma × Ascorbic Acid × Clear all
NCT02168270 2023-11-24

Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma

University of Nebraska

Phase 1 Terminated
4 enrolled 6 charts
CNSSarcoma

Astrocytoma, Glioblastoma, Oligodendroglioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡